Qualitative simulation of dynamic physiological models using the KEE environment

https://doi.org/10.1016/0933-3657(92)90037-PGet rights and content

Abstract

In this work we present a new method for qualitative simulation of dynamical systems. The method can be used to describe the possible time evolutions of different models, starting from a qualitative description of the main relationships among quantities. The status of each quantity in the model, at any instant, is synthesized using two main attributes, i.e. magnitude and rate.of.change; both can assume one of three possible qualitative values. The inference engine is based both on lisp programs and on different classes of production rules. Among others, the ‘certainty.rules’ have the task of recognizing all facts which can be asserted with certainty within the present context, whereas the ‘hypothesis.rules’ generate alternative contexts (or worlds) in which reasoning can continue independently of the others. Some examples of qualitative simulations obtained on simple models of the cardiovascular system are presented, and the main advantages and limitations of the method are discussed.

References (11)

There are more references available in the full text version of this article.

Cited by (8)

  • First principles pharmacokinetic modeling: A quantitative study on Cyclosporin

    2013, Computers and Chemical Engineering
    Citation Excerpt :

    Pharmacokinetic models establish relationships between drug dosage, bioaccumulation and clearance utilizing dose–response measurements. Classical pharmacokinetic (PK) models relate anatomy and physiology parametrically to dose–response data while fitting exponential functions with multiple adjustable constants or exponential coefficients (Buss & Stepanek, 1993; Legg & Rowland, 1987; Ursino, Avanzolini, & Barbini, 1992). The resulting black-box formulae permit the computation of the area under the curve (AUC), the plasma half-life of elimination (t1/2) or the intrinsic clearance rates.

  • Interspecies scaling in pharmacokinetics: A novel whole-body physiologically based modeling framework to discover drug biodistribution mechanisms in vivo

    2012, Journal of Pharmaceutical Sciences
    Citation Excerpt :

    Pharmacokinetic models aim to establish relationships between drug administration, bioaccumulation, and elimination from dose–response measurements in vivo. Typical PK models fit parametric functions with multiple adjustable constants or exponential coefficients.2–4 Nonmechanistic parameters such as volume of distribution, area under the curve (AUC), and intrinsic clearance rates are usually computed.

View all citing articles on Scopus
View full text